- Home
- NIC vs BCRX Comparison
NIC vs BCRX Comparison
Compare NIC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIC
- BCRX
- Stock Information
- Founded
- NIC 2000
- BCRX 1986
- Country
- NIC United States
- BCRX United States
- Employees
- NIC N/A
- BCRX N/A
- Industry
- NIC Major Banks
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NIC Finance
- BCRX Health Care
- Exchange
- NIC Nasdaq
- BCRX Nasdaq
- Market Cap
- NIC 1.6B
- BCRX 1.9B
- IPO Year
- NIC N/A
- BCRX 1994
- Fundamental
- Price
- NIC $117.18
- BCRX $9.21
- Analyst Decision
- NIC Buy
- BCRX Buy
- Analyst Count
- NIC 4
- BCRX 6
- Target Price
- NIC $119.00
- BCRX $15.50
- AVG Volume (30 Days)
- NIC 51.4K
- BCRX 3.1M
- Earning Date
- NIC 04-15-2025
- BCRX 02-24-2025
- Dividend Yield
- NIC 0.96%
- BCRX N/A
- EPS Growth
- NIC 97.30
- BCRX N/A
- EPS
- NIC 8.05
- BCRX N/A
- Revenue
- NIC $346,482,000.00
- BCRX $412,579,000.00
- Revenue This Year
- NIC N/A
- BCRX $38.44
- Revenue Next Year
- NIC $3.93
- BCRX $21.23
- P/E Ratio
- NIC $14.54
- BCRX N/A
- Revenue Growth
- NIC 27.15
- BCRX 29.92
- 52 Week Low
- NIC $75.24
- BCRX $4.03
- 52 Week High
- NIC $120.26
- BCRX $9.50
- Technical
- Relative Strength Index (RSI)
- NIC 60.73
- BCRX 65.48
- Support Level
- NIC $115.96
- BCRX $8.63
- Resistance Level
- NIC $119.62
- BCRX $9.00
- Average True Range (ATR)
- NIC 2.31
- BCRX 0.36
- MACD
- NIC -0.03
- BCRX 0.07
- Stochastic Oscillator
- NIC 72.60
- BCRX 85.20
About NIC Nicolet Bankshares Inc.
Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.